Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis

Cell Death and Disease

Volumn 1, Issue 7, 2010, Pages

  Chan, K S ^a   Wong, C H ^a   Huang, Y F ^a,b   Li, H Y ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Nuclear transport; RanGTP; Survivin; Ubiquitination

Indexed keywords

SURVIVIN; BIRC5 PROTEIN, HUMAN; CELL RECEPTOR; EXPORTIN 1 PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; KARYOPHERIN; MACROPHAGE STIMULATING PROTEIN; ONCOPROTEIN; SCATTER FACTOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; UBIQUITINATION; ACTIVE TRANSPORT; CELL NUCLEUS; GENETICS; HELA CELL; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL NUCLEUS; HELA CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KARYOPHERINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITINATION;

EID: 78649308461     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.34     Document Type: Article

References (31)

1. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 1999;96:1457-1462. (Pubitemid 29098472)
2. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 2003;22:2729-2740. (Pubitemid 36712369)
3. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 2001;40:1117-1123. (Pubitemid 32108606)
4. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58:5315-5320. (Pubitemid 28551107)
5. Wheatley SP, McNeish IA. Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev Cytol 2005;247:35-88. (Pubitemid 41774364)
6. Ferrandina G, Legge F, Martinelli E, Ranelletti FO, Zannoni GF, Lauriola L et al. Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters. Br J Cancer 2005;92:271-277. (Pubitemid 40343140)
7. Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD et al. Prognostic importance of survivin in breast cancer. Br J Cancer 2003;88:1077-1083. (Pubitemid 36560779)
8. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 2001;163:109-116. (Pubitemid 32121836)
9. Temme A, Rodriguez JA, Hendruschk S, Gunes S, Weigle B, Schakel K et al. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett 2007;250:177-193. (Pubitemid 46546648)
10. Tonini G, Vincenzi B, Santini D, Scarpa S, Vasaturo T, Malacrino C et al. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br J Cancer 2005;92:2225-2232. (Pubitemid 40966261)
11. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008;14:5000-5005.
12. Stauber RH, Mann W, Knauer SK. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 2007;67:5999-6002. (Pubitemid 47037475)
13. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspaseindependent mechanisms. Oncogene 2004;23:7494-7506. (Pubitemid 39389691)
14. Lu B, Mu Y, Cao C, Zeng F, Schneider S, Tan J et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res 2004;64:2840-2845. (Pubitemid 38500623)
15. Knauer SK, Mann W, Stauber RH. Survivin's dual role: an export's view. Cell Cycle 2007;6:518-521. (Pubitemid 46440421)
16. Rodriguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res 2002;275:44-53.
17. Stauber RH, Rabenhorst U, Rekik A, Engels K, Bier C, Knauer SK. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic 2006;7:1461-1472. (Pubitemid 44524519)
18. Knauer SK, Kramer OH, Knosel T, Engels K, Rodel F, Kovacs AF et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J 2007;21:207-216. (Pubitemid 46052558)
19. Connell CM, Colnaghi R, Wheatley SP. Nuclear survivin has reduced stability and is not cytoprotective. J Biol Chem 2008;283:3289-3296.
20. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 2000;113(Part 23):4363-4371. (Pubitemid 32000697)
21. Colnaghi R, Connell CM, Barrett RM, Wheatley SP. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 2006;281:33450-33456. (Pubitemid 46036726)
22. Kihlmark M, Imreh G, Hallberg E. Sequential degradation of proteins from the nuclear envelope during apoptosis. J Cell Sci 2001;114(Part 20):3643-3653. (Pubitemid 33041046)
23. Walther TC, Fornerod M, Pickersgill H, Goldberg M, Allen TD, Mattaj IW. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. EMBO J 2001;20:5703-5714. (Pubitemid 33010047)
24. Mosammaparast N, Pemberton LF. Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol 2004;14:547-556. (Pubitemid 39296617)
25. Wong CH, Chan H, Ho CY, Lai SK, Chan KS, Koh CG et al. Apoptotic histone modification inhibits nuclear transport by regulating RCC1. Nat Cell Biol 2009;11:36-45.
26. Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 2005;114:509-512. (Pubitemid 40349608)
27. Kutay U, Guttinger S. Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol 2005;15:121-124. (Pubitemid 40332533)
28. Hutten S, Kehlenbach RH. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 2007;17:193-201. (Pubitemid 46507806)
29. Petosa C, Schoehn G, Askjaer P, Bauer U, Moulin M, Steuerwald U et al. Architecture of CRM1/Exportin1 suggests how cooperativity is achieved during formation of a nuclear export complex. Mol Cell 2004;16:761-775. (Pubitemid 39586534)
30. Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004;279:34087-34090. (Pubitemid 39318028)
31. Li HY, Zheng Y. Phosphorylation of RCC1 in mitosis is essential for producing a high RanGTP concentration on chromosomes and for spindle assembly in mammalian cells. Genes Dev 2004;18:512-527. (Pubitemid 38372809)